Terms: = Lymphoma AND PAX5, Q02548, 5079, ENSG00000196092, BSAP AND Clinical Outcome
11 results:
1. Frequency and Correlation of Common Genes Copy Number Alterations in Childhood Acute Lymphoblastic Leukemia with Prognosis.
Hosein Pour Feizi A; Zeinali S; Toporski J; Sheervalilou R; Mehranfar S
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3493-3500. PubMed ID: 33369444
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic gene alterations and clonal changes in childhood B-ALL.
Erbilgin Y; Firtina S; Mercan S; Hatirnaz Ng O; Karaman S; Tasar O; Karakas Z; Celkan TT; Zengin E; Sarper N; Yildirmak ZY; Sisko S; Ozbek U; Sayitoglu M
Leuk Res; 2019 Aug; 83():106159. PubMed ID: 31228652
[TBL] [Abstract] [Full Text] [Related]
3. Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia.
Steeghs EMP; Boer JM; Hoogkamer AQ; Boeree A; de Haas V; de Groot-Kruseman HA; Horstmann MA; Escherich G; Pieters R; den Boer ML
Sci Rep; 2019 Mar; 9(1):4634. PubMed ID: 30874617
[TBL] [Abstract] [Full Text] [Related]
4. pax5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia.
Bastian L; Schroeder MP; Eckert C; Schlee C; Tanchez JO; Kämpf S; Wagner DL; Schulze V; Isaakidis K; Lázaro-Navarro J; Hänzelmann S; James AR; Ekici A; Burmeister T; Schwartz S; Schrappe M; Horstmann M; Vosberg S; Krebs S; Blum H; Hecht J; Greif PA; Rieger MA; Brüggemann M; Gökbuget N; Neumann M; Baldus CD
Leukemia; 2019 Aug; 33(8):1895-1909. PubMed ID: 30842609
[TBL] [Abstract] [Full Text] [Related]
5. Tumor CD73/A2aR adenosine immunosuppressive axis and tumor-infiltrating lymphocytes in diffuse large B-cell lymphoma: correlations with clinicopathological characteristics and clinical outcome.
Wang X; Zhang T; Song Z; Li L; Zhang X; Liu J; Liu X; Qiu L; Qian Z; Zhou S; Feng L; Hu G; Meng B; Zhai Q; Ren X; Fu K; Li L; Wang P; Zhang H
Int J Cancer; 2019 Sep; 145(5):1414-1422. PubMed ID: 30664812
[TBL] [Abstract] [Full Text] [Related]
6. B-cell identity as a metabolic barrier against malignant transformation.
Chan LN; Müschen M
Exp Hematol; 2017 Sep; 53():1-6. PubMed ID: 28655536
[TBL] [Abstract] [Full Text] [Related]
7. Intrafollicular Epstein-Barr virus-positive large B cell lymphoma. A variant of "germinotropic" lymphoproliferative disorder.
Lorenzi L; Lonardi S; Essatari MH; Pellegrini V; Fisogni S; Gazzola A; Agostinelli C; Vermi W; Rossi G; Massarelli G; Pileri SA; Facchetti F
Virchows Arch; 2016 Apr; 468(4):441-50. PubMed ID: 26762526
[TBL] [Abstract] [Full Text] [Related]
8. Expression of TIA1 and pax5 in Classical Hodgkin lymphoma at Initial Diagnosis May Predict clinical outcome.
Nguyen TT; Frater JL; Klein J; Chen L; Bartlett NL; Foyil KV; Kreisel FH
Appl Immunohistochem Mol Morphol; 2016 Jul; 24(6):383-91. PubMed ID: 26067141
[TBL] [Abstract] [Full Text] [Related]
9. Expression of programmed death-1 (CD279) in primary cutaneous B-cell lymphomas with correlation to lymphoma entities and biological behaviour.
Mitteldorf C; Bieri M; Wey N; Kerl K; Kamarachev J; Pfaltz M; Kutzner H; Roncador G; Tomasini D; Kempf W
Br J Dermatol; 2013 Dec; 169(6):1212-8. PubMed ID: 23937075
[TBL] [Abstract] [Full Text] [Related]
10. Anaplastic large cell lymphoma, ALK-negative.
Ferreri AJ; Govi S; Pileri SA; Savage KJ
Crit Rev Oncol Hematol; 2013 Feb; 85(2):206-15. PubMed ID: 22789917
[TBL] [Abstract] [Full Text] [Related]
11. Rare lymphoid neoplasms coexpressing B- and T-cell antigens. The role of PAX-5 gene methylation in their pathogenesis.
Lazzi S; Bellan C; Onnis A; De Falco G; Sayed S; Kostopoulos I; Onorati M; D'Amuri A; Santopietro R; Vindigni C; Fabbri A; Righi S; Pileri S; Tosi P; Leoncini L
Hum Pathol; 2009 Sep; 40(9):1252-61. PubMed ID: 19368954
[TBL] [Abstract] [Full Text] [Related]
